Zyprexa

vs.

the Medical Elite,” by Mark Sircus Ac, OMD in June 22, 2005.

"Many of these drugs carry black box warning to alert MD’s about the dangers of diabetes," Mr.

Sircus pointed out.

"The most studied adverse effect of the newer generation of antipsychotics is their association with hyperglycemia, in some cases leading to ketoacidosis, coma, or death." According to Dr.

Kruszewski, the new atypicals substantially increase the risk of obesity, diabetes type II, hypertension, heart attacks, cardiovascular complications, and stroke.

“The drug makers had this information and simply ignored the problem," he says.

Dr.

Kruszewski is apparently correct judging by hidden studies that have come to light.

After years of prescribing Risperdal for off-label use by millions of patients in all age groups, on July 24, 2004, the Miami Herald reported the “maker of a billion-dollar antipsychotic medication has acknowledged misleading doctors and other healthcare providers about the safety of its product, minimizing potentially deadly side effects.” As it turns out, the maker of Risperdal had two billion good reasons to hide the dangers associated with the drug because Janssen earns about $2.1 billion in annual sales from Risperdal, according to the Herald.

During his interview with Street Spirit, Mr.

Whitaker summed up the devastating effects on society as ...

Read more...